Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
177 studies found for:    weill AND med | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Conditions: Batten Disease;   Late Infantile Neuronal Lipofuscinosis
Intervention: Genetic: AAVrh.10CUhCLN2 vector
2 Recruiting AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis With Uncommon Genotypes or Moderate/Severe Impairment
Conditions: Late Infantile Neuronal Ceroid Lipofuscinosis;   Batten Disease
Intervention: Biological: AAVrh.10CUCLN2
3 Recruiting Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis
Conditions: Batten Disease;   Late Infantile Neuronal Lipofuscinosis
Intervention:
4 Not yet recruiting Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
Conditions: Peanut Allergy;   Allergic/Atopic Individuals;   Non Allergic Individuals;   Allergic Individuals Receiving Xolair Therapy
Intervention:
5 Recruiting Aortic Wall and Left Ventricular Mechanics: Echocardiographic and Hemodynamic Analysis
Condition: Coronary Artery Bypass Graft or Valve Surgery
Intervention: Procedure: TEE report
6 Recruiting Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
Condition: Posttraumatic Stress Disorder
Interventions: Drug: DCS;   Other: Placebo
7 Recruiting Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Conditions: Tourette Disorder;   Chronic Tic Disorder
Intervention: Behavioral: Comprehensive Behavioral Treatment for Tic Disorders
8 Unknown  Treatment Targets for Chronic Hypertension in Pregnancy
Conditions: Pregnancy Toxemia;   Hypertension;   Proteinuria
Interventions: Drug: methyldopa;   Drug: labetalol;   Drug: nifedipine;   Drug: clonidine
9 Unknown  Assessing the Impact of Health Information Exchange (HIE) on Healthcare Utilization
Conditions: Health Information Technology;   Health Information Exchange;   Virtual Health Record;   Health Care Utilization
Intervention: Other: Virtual Health Record (VHR)
10 Recruiting Intraarterial Cerebral Infusion of Avastin for Vestibular Schwannoma (Acoustic Neuroma)
Condition: Vestibular Schwannoma
Intervention: Drug: Bevacizumab (Avastin)
11 Recruiting Sensing Atrial High Rate Episodes With in Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Condition: Atrial Fibrillation
Intervention: Device: Implantable cardioverter-defibrillator DX system (Biotronik)
12 Recruiting Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
Condition: Pulmonary Diseases
Intervention:
13 Unknown  Use of Multiphoton Microscopy in the Diagnosis of Cancer
Conditions: Bladder Cancer;   Prostate Cancer
Intervention: Other: Multiphoton microscopy
14 Unknown  Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
Condition: Thalassemia
Interventions: Drug: Deferoxamine;   Drug: Deferasirox
15 Not yet recruiting The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study
Condition: Thalassemia Major
Interventions: Drug: Vitamin D3;   Drug: Placebo
16 Unknown  Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
Condition: Cardiac Surgery
Interventions: Drug: Amiodarone;   Procedure: Cardioversion
17 Unknown  Increasing Use of Mental Health Services
Condition: Major Depression
Intervention: Behavioral: Treatment Initiation Program (TIP) intervention
18 Recruiting Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
Condition: Posttraumatic Stress Disorder
Interventions: Drug: D-Cycloserine;   Other: placebo
19 Recruiting Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery
Condition: Video-assisted Thoracic Surgery
Interventions: Drug: IV Acetaminophen;   Drug: Saline Placebo
20 Recruiting Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: PD 0332991;   Drug: bortezomib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years